A soluble form of the murine common γ chain is present at high concentrations in vivo and suppresses cytokine signaling

Blood

Volumn 97, Issue 1, 2001, Pages 183-191

  Meißner, Udo ^a   Blum, Horst ^a   Schnare, Markus ^a   Röllinghoff, Martin ^a   Gessner, André ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN GAMMA CHAIN; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7;

ANIMAL CELL; ARTICLE; CELL GROWTH; FEMALE; IMMUNE RESPONSE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

EID: 0035170681     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.1.183     Document Type: Article

References (61)

1. The common gamma-chain for multiple cytokine receptors
2. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits
3. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signalling pathway
4. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in human
5. Structural and functional basis for JAK3-deficient severe combined immunodeficiency
6. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain
7. Detective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain
8. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
9. Detects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
10. Defective lymphoid development in mice lacking Jak3
11. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency
12. Soluble receptors for cytokines and growth factors. II: Generation and biological function
13. Soluble cytokine receptors: Their roles in immunoregulation, disease, and therapy
14. Soluble receptors in human disease
15. Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors
16. A metallopreteinase disintegrin that releases tumour-necrosis factor-α from cells
17. Metalloprotease-disintegrins: Links to cell adhesion and cleavage of TNF alpha and Notch
18. The soluble interleukin-6 receptor is generated by shedding
19. The molecular basis for the generation of the human soluble interleukin 2 receptor
20. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein
21. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor
22. The murine interleukin-4 receptor: Molecular cloning and characterization of secreted and membrane bound forms
23. Two different stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor
24. Isolation of a cDNA encoding a potential soluble receptor for human erythropoietin
25. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit
26. Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily
27. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism
28. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130
29. Recombinant soluble interleukin-4 (lL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis
30. Evidence that natural murine soluble interleukin 4 receptors may act as transport protein
31. Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody
32. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
33. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
34. Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice
35. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
36. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
37. Differential regulation of IL-9 expression after infection with Leishmania major in susceptible and resistant mice
38. An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2
39. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus
40. Studies on the mechanism of polyclonal B cell stimulation by Th2 cells
41. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells
42. Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell line can substitute for antigen and antigen-presenting cells in the activation of T cells
43. Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages
44. Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes
45. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: Chromosomal mapping and tissue specificity of IL-2R gamma chain expression
46. Structural design and molecular evolution of a cytokine receptor superfamily
47. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain
48. Serum soluble interleukin-6 receptor in MRL/Ipr mice is elevated with age and mediates the interleukin-6 signal
49. LPS-induced sTNF-receptor release in vivo in a murine model: Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma
50. Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains
51. The common γ-chain for multiple cytokine receptors: Its role in the multiple cytokine receptor complexes and T cell development in XSCID
52. Expression of the common cytokine receptor gamma chain by murine dendritic cells including epidermal Langerhans cells
53. The role of Jak3 in lymphoid development, activation, and signaling
54. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: Critical role of tumor necrosis factor
55. Membrane protein secretases
56. The soluble human IL-6 receptor: Mutational characterization of the proteolytic cleavage site
57. Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation
58. Functional cleavage of the common cytokine receptor gamma chain (γc) by calpain
59. Putative gamma-subunit of the IL-2 receptor is detected in low, intermediate, and high affinity IL-2 receptor-bearing cells
60. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
61. Interleukin-2 (IL-2) receptor γ chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding